NCT07212751Active, not recruiting
Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The study aims at determining if the presence of adverse plaque features identified from the CT angiogram can help determine prognosis and guide treatment options.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 22000 (estimated)
- First submitted
- 7 Jul 2025
- Start date
- 29 Jan 2020
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- The University of Hong Kong
- Diseases
- Coronary artery disease, Stroke
- NCT number
- NCT07212751
What you commit to
- Study type: Observational
- Planned participants: 22000
- From 29 Jan 2020 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Patient who did not undergo cardiac CT scan due to inability to undergo cardiac CT scanning, kidney failure (serum creatinine \>250 μmol/L or estimated glomerular filtration rate \<30 mL/min), major allergy to contrast.
Who the study is looking for
- Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment
- If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.
Age in the registry: 18 years to 99 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.